Elequin Capital’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-102
Closed -$31.5K 634
2023
Q2
$31.5K Hold
102
0.02% 202
2023
Q1
$31.1K Hold
102
0.02% 141
2022
Q4
$30.3K Buy
102
+57
+127% +$16.8K 0.01% 352
2022
Q3
$13K Buy
+45
New +$13.1K ﹤0.01% 223

Other funds holding XAGE

Elequin Capital's XAGE Position: Q3 2023 in Review

Elequin Capital sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2023, closing a stake of 102 shares — an estimated $31.5K sold.

Elequin Capital first reported a position in XAGE in Q3 2022 and held it in 4 quarters. The position peaked at $31.5K in Q2 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

  • Elequin Capital reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Elequin Capital sold 102 Longevity Health Holdings, Inc. Common Stock shares in Q3 2023, an estimated $31.5K.
  • Elequin Capital first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Elequin Capital's Longevity Health Holdings, Inc. Common Stock position peaked at $31.5K in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2023.

Based on Elequin Capital's 13F filing for Q3 2023, filed 14 Nov 2023.